RAY-B.ST
RAY-B.ST
SE0000135485
RaySearch Laboratories AB ser.
Loading chart...

Company Profile

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; Machine Learning; and Liver Ablation Solutions. The company was founded in 2000 and is headquartered in Stockholm, Sweden.

Related stocks

PHR
PHR • United States
Phreesia, Inc.
10.81 USD
670.99M USD 1Y -54.2%
328130.KQ
328130.KQ • South Korea
Lunit
11,370 KRW
631.77M USD 1Y -40.3%
2192.HK
2192.HK • China
MEDLIVE
6.59 HKD
621.54M USD 1Y -48.6%
TALK
TALK • United States
Talkspace, Inc.
5.25 USD
870.57M USD
OMDA
OMDA • United States
Omada Health, Inc.
21.55 USD
1.32B USD 1Y -13.2%
4483.T
4483.T • Japan
JMDC INC
3,720 JPY
1.54B USD 1Y -20%
INDGN.NS
INDGN.NS • India
INDEGENE LIMITED
580.1 INR
1.44B USD 1Y +4.8%
OMCL
OMCL • United States
Omnicell, Inc.
35.82 USD
1.63B USD 1Y +10.7%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
50.2% p.a.
Max Drawdown (5Y)
-55.0%
Sharpe Ratio (5Y)
0.47
Beta Factor
0.87
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (50.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -84.7% in the extended horizon.
ende